RBC Downgrades Medical Properties Trust to Underperform
The explicit downgrade and lower target provide a clear negative analyst signal, but the view is not independently confirmed here.
Public signal · 1-minute delayed
Source-backed market context you can read and share without an account.
The explicit downgrade and lower target provide a clear negative analyst signal, but the view is not independently confirmed here.
What happened, with direct paths to the underlying reporting
RBC downgraded MPT to Underperform and set a $2 target versus a posted price of $2.44, indicating roughly 18% downside to the target.
Target: $2
Posted price: $2.44
Analyst firm: RBC Capital
Analyst: Michael Carroll
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.